CLOs on the Move

Metropolitan Medical Lab

www.qcmetro.com

 
Metropolitan Medical Lab is a East Moline, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.qcmetro.com
  • 1520 Seventh St
    East Moline, IL USA 61244
  • Phone: 309.762.8555

Executives

Name Title Contact Details

Similar Companies

Test America

TestAmerica Drilling is a licensed drilling contractor specializing in environmental and geotechnical subsurface investigations. TestAmerica Drilling Corporation (TAD) was founded in 1986 and became part of the TestAmerica Corporation in 1998. As one of

American Environmental Testing

American Environmental Testing is a Burbank, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Penn Services Group Inc

Penn Services Group Inc is a Exton, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Jounce Therapeutics

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients through a biomarker-driven approach. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within the human tumor microenvironment to prioritize targets, and then identifies related biomarkers designed to match the right immunotherapy to the right patient. Jounce is developing two clinical-stage programs as well as advancing and building out its broad and wholly-owned discovery pipeline of immuno-oncology targets, including those expressed on T-regulatory cells, macrophages and stromal cells. Jounce`s lead product candidate, vopratelimab, is a monoclonal antibody that binds to and activates ICOS and is currently being assessed in a Phase 2 clinical trial. JTX-4014 is a PD-1 inhibitor intended for use in combination with future pipeline products, and Jounce has completed enrollment in the JTX-4014 Phase 1 clinical trial. In addition, Jounce has exclusively licensed worldwide rights to JTX-8064, a LILRB2 receptor antagonist, to Celgene. For more information, please visit www.jouncetx.com. We have many career opportunities at Jounce and are looking for exceptional individuals who share our passion and perseverance for developing highly durable cancer immunotherapies that can dramatically impact and improve patients` lives.

Pathology Services Inc

Pathology Services Inc is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.